Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) Mutations
Matteo M. Guerrini(Fondazione Humanitas per la Ricerca), Annalisa Frattini(Institute of Genetic and Biomedical Research), Barbara Cassani(Humanitas University), Luigi D. Notarangelo(Harvard University), Alessandra Pangrazio(Institute of Biomedical Technologies), Ashok Vellodi(Great Ormond Street Hospital), Daniele Moratto(University of Brescia), İlhan Tezcan(Hacettepe University Hospital), Paolo Vezzoni(Institute of Genetic and Biomedical Research), Paul J. Orchard(University of Minnesota), Jill Clayton‐Smith(St Mary's Hospital), Cristina Sobacchi(Humanitas University), Sara Şebnem Kılıç(Bursa Uludağ Üni̇versi̇tesi̇), David Mellis(University of Aberdeen), Anna Villa(Institute of Genetic and Biomedical Research), Michael J. Rogers(Garvan Institute of Medical Research), Mario Abinun(North Tyneside General Hospital), Fraser P. Coxon(University of Aberdeen), Evelina Mazzolari(University of Brescia), Julie C. Crockett(University of Florida), Miep Helfrich(University of Aberdeen)
Cited by 307
Related Papers
Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)
|Cell|2000|1.6k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM
|Nature|1998|942
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889